December 13, 2025
Headlines

Demystifying Intra-Cellular Therapies: Insights From 6 Analyst Reviews

Sumain Faisal01 mins

Latest Ratings for ITCI

Date Firm Action From To
Mar 2022 SVB Leerink Maintains Outperform
Feb 2022 Needham Maintains Buy
Feb 2022 Goldman Sachs Initiates Coverage On Buy

View More Analyst Ratings for ITCI

View the Latest Analyst Ratings

read more

Leave a Reply

Your email address will not be published. Required fields are marked *

Related News